Groupama Asset Managment purchased a new stake in shares of Globe Life Inc. (NYSE:GL – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 16,374 shares of the company’s stock, valued at approximately $1,800,000.
Other large investors also recently bought and sold shares of the company. Versant Capital Management Inc grew its stake in shares of Globe Life by 388.0% during the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after purchasing an additional 194 shares during the period. Albion Financial Group UT acquired a new stake in Globe Life during the fourth quarter valued at $28,000. Rakuten Securities Inc. purchased a new position in Globe Life in the fourth quarter valued at $28,000. Avalon Trust Co acquired a new position in shares of Globe Life in the fourth quarter worth about $41,000. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Globe Life by 32.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock worth $41,000 after acquiring an additional 90 shares in the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.
Globe Life Stock Performance
NYSE GL opened at $133.30 on Thursday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The stock’s fifty day moving average is $124.75 and its two-hundred day moving average is $114.54. The firm has a market capitalization of $11.10 billion, a P/E ratio of 11.15 and a beta of 0.77. Globe Life Inc. has a fifty-two week low of $38.95 and a fifty-two week high of $135.00.
Globe Life Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, April 3rd will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.81%. The ex-dividend date is Thursday, April 3rd. This is a positive change from Globe Life’s previous quarterly dividend of $0.24. Globe Life’s payout ratio is presently 9.04%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the company. Wells Fargo & Company upped their price target on Globe Life from $126.00 to $141.00 and gave the stock an “overweight” rating in a report on Wednesday, February 19th. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $136.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday. Piper Sandler upped their price objective on shares of Globe Life from $140.00 to $152.00 and gave the stock an “overweight” rating in a research report on Wednesday. Jefferies Financial Group lifted their target price on shares of Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research report on Tuesday, December 10th. Finally, Morgan Stanley upped their price target on shares of Globe Life from $125.00 to $126.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $138.45.
Check Out Our Latest Report on Globe Life
Insider Activity at Globe Life
In other Globe Life news, Director Mark A. Blinn sold 3,000 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the transaction, the director now owns 5,122 shares of the company’s stock, valued at $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 11,000 shares of Globe Life stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the sale, the chief executive officer now owns 18,948 shares of the company’s stock, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 61,338 shares of company stock worth $7,239,630. Insiders own 1.51% of the company’s stock.
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- How to Short a Stock in 5 Easy StepsĀ
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Following Congress Stock Trades
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.